SP100 and cancer: In keeping with previous studies (Borden and Manuelidis, 1988; Meaburn et al., 2009; Leshner et al., 2016; Meaburn et al., 2016), we find similar positioning patterns for both SP100 and TGFB3 amongst normal tissues and between normal and benign disease tissues, highlighting that the gene repositioning in cancer tissues were specific to cancer.